Log In
Print
BCIQ
Print
Print this Print this
 

BIIB057, PRT062607, PRT2607 (formerly P505-15)

  Manage Alerts
Collapse Summary General Information
Company Portola Pharmaceuticals Inc.
DescriptionOral spleen tyrosine kinase (SYK) inhibitor
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of ActionSyk kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today